Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Motor Activity × Resistance Training × Clear all

Phase

Phase NA 22 Phase 3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Polycystic Ovary Syndrome 1 Motor Activity 1 Insulin Resistance 1 Breast Neoplasms 1 Body Weight 1

Interventions

Exercise 8 tislelizumab 1 Vitamin D 1 Tea 1 Resistance Training 1 Probiotics 1 Oxaliplatin 1 Nutrition Assessment 1 Metformin 1 Leucovorin 1 Fluorouracil 1 Fish Oils 1 Diet Therapy 1 Diet 1 Curcumin 1 Counseling 1 Capecitabine 1 Caloric Restriction 1 Andrographis paniculata extract 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01482286 2022-03-15

PULSE

Pennington Biomedical Research Center

Phase 3 Terminated

32 enrolled 10 charts

Body Weight, Insulin Resistance, Motor Activity, Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon ⚡